Topic: "Neurology Resident Research Grand Rounds"
Speakers: Maryam A. Haq, M.D., Hamza M. Ahmed, M.D., Raman Singh, M.D., Hassan Imtiaz, M.D.
Speaker Disclosures: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speakers and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable. Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.
Learning Objectives:
Nursing-Led Rounds in the OU Neurosciences ICU – A QI Project
Maryam A. Haq, M.D.
- Discuss the role of nurses in the Neurosciences ICU setting.
- Discuss the potential impact of nursing-led rounds on patient outcomes in the Neurosciences ICU.
Assessing Rates of Hemorrhagic and Thromboembolic Complications in Patients Treated with Various Post Procedural Antiplatelet or Heparin Based Therapy Regimens after Treatment of Ruptured Aneurysms with Coiling or Clipping – A Meta-analysis and Review of Literature
Hamza M. Ahmed, M.D.
- Describe current approaches to post procedural anti-thrombotic therapy after treatment of ruptured intracranial aneurysms.
- Describe the findings of a meta-analysis comparing rates of hemorrhagic and thromboembolic complications among patients treated with antiplatelet therapy vs heparin-based anticoagulation after treatment of ruptured aneurysms via coiling or clipping.
Thyroid Hormones in Acute Ischemic Stroke (AIS): Possible Clinical Application
Raman Singh, M.D.
- Establish correlation between T3, T4, TSH levels and initial National Institutes of Health Stroke Scale (NIHSS) in patients with acute ischemic stroke.
- Review the neuroprotective benefits of administering thyroid in experimental mice.
Evolving Trends in Antiseizure Medication Use: The Emerging Role of Lacosamide in Status Epilepticus Management – A Single-Center Retrospective Study
Hassan Imtiaz, M.D.
- Review trends in antiseizure medication use for status epilepticus between 2019 and 2022.
- Describe the increasing use of Lacosamide as a second-line agent in status epilepticus management.
- Summarize the decline in use of traditional agents like phenytoin and phenobarbital over time.
CE Credits: 1